1 37 patients (23.1%), and the success rate of
choledochal cannulation in the first ERCP procedure was
2 There was no difference in the
choledochal cannulation rate between patients with and w
3 The rate of
choledochal cannulation, post ERCP hyperamylasemia and P
4 ture (n = 18), malignant stricture (n = 12),
choledochal cyst (n = 5), choledocholithiasis (n = 3), i
5 from 32 subjects (20 with biliary atresia or
choledochal cyst and 12 controls) were tested.
6 9%) an operation to treat biliary atresia or
choledochal cyst in the preceding year.
7 alse-positive findings); four demonstrated a
choledochal cyst; and two were equivocal.
8 Choledochal cysts (CCs) are rare, with risk of infection
9 Extrahepatic biliary atresia (EHBA) and
choledochal cysts (CDC) are important causes of obstruct
10 ultiple diseases, including biliary atresia,
choledochal cysts and gallbladder agenesis.
11 However, most surgical series of
choledochal cysts have reported few choledochoceles beca
12 r suppressor gene nf2, develops extrahepatic
choledochal cysts in the common bile duct, suggesting th
13 erefore, we conclude that classifications of
choledochal cysts should not include choledochoceles.
14 th choledochoceles differ from patients with
choledochal cysts with respect to age, gender, presentat
15 A total of 146 patients with "
choledochal cysts" including 45 children (31%) and 28 wi
16 iary cirrhosis, cholangitis, cholelithiasis,
choledochal cysts, hepatitis B virus, hepatitis C virus,
17 11 for bile duct injury, cholangiocarcinoma,
choledochal cysts, or benign strictures; the procedures
18 iversity Hospitals to identify patients with
choledochal cysts.
19 edochoceles to Todani Types I, II, IV, and V
choledochal cysts.
20 bserved in biliary cells in individuals with
choledochal cysts.
21 eles have been classified as Todani Type III
choledochal cysts.
22 Choledochal pathology was divided into two groups regard
23 (OR, 15.59; 95% CI: 4.61, 68.62; P < .001),
choledochal ring sign (OR, 5.73; 95% CI: 2.11, 17.05; P